Recent Updates
Recently added Catalysts
HBIO Positive Sentiment Score: 70/100

Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET

Tuesday, February 28, 2023 2 min read
Key Takeaway: Harvard Bioscience, Inc. has announced it will release its financial results for the fourth quarter ending December 31, 2022, prior to the market opening on March 9, 2023. An earnings conference call will follow at 8:00 AM ET, allowing participants to ask questions after registering. The investor relations section on their website will provide access to financial information and a related slide presentation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Harvard Bioscience is set to announce its financial results, signaling transparency and engagement with investors.
  • The scheduled conference call provides an opportunity for stakeholders to directly engage and ask questions.
  • The company continues to support essential life science applications, indicating its relevance and importance in the industry.

Full Press Release Details

HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on March 9, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who want to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who want to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Interim Chief Financial Officer

Frequently Asked Questions

When will Harvard Bioscience announce its Q4 2022 financial results?

Harvard Bioscience will announce its Q4 2022 financial results on March 9, 2023.

What time is the conference call for discussing the results?

The conference call will take place at 8:00 a.m. Eastern Time.

How can participants join the conference call?

Participants must register to receive dial-in numbers and a unique PIN.

Where can I find the financial information presented on the call?

Financial information will be available under the Investor Relations section.

What services does Harvard Bioscience offer?

Harvard Bioscience offers technologies for life science research and pharmaceutical development.

Tags: HBIO Viatris Investor Conferences Healthcare Harvard Bioscience Q4 2022 financial results conference call
Last updated: Feb 28, 2023